ALRUD’s Russian antitrust team represented Danaher Corporation in the acquisition of General Electric's biopharmaceutical business
December, 2020 - Moscow, Russia
<p>ALRUD Law Firm advised <a href="https://www.danaher.com/" title="Danaher Corporation">Danaher Corporation</a>, an American manufacturer of professional medical, industrial and commercial equipment, on its $21.4 billion acquisition of <a href="https://www.ge.com/" title="General Electric’s">General Electric’s</a> Healthcare Life Sciences Biopharma Business (GE BioPharma).</p> <p>Due to the parties' diversified biotechnology portfolios, the transaction could lead to significant overlaps in the relevant Russian medical equipment markets. To secure the clearance of the transaction by FAS Russia (Federal Antimonopoly Service), ALRUD Antitrust Team prepared a detailed analysis of the relevant Russian markets and proved the absence of any negative consequences for the state of competition in Russia. As a result, the transaction has been successfully cleared by the regulator with minimal remedies.</p> <p><em><strong>$21<br>bln</strong> Transaction value</em></p> <p>ALRUD represented Danaher Corporation with a team led by <a href="https://www.alrud.com/partner/GermanZakharov" title="German Zakharov">German Zakharov</a>, ALRUD Partner and Head of the Antitrust Practice, and <span data-color='#ff351b'>Ruslana Karimova,</span> ALRUD Senior Associate.</p> <p>This project has shown the importance of preparing and presenting detailed market analysis for a successful clearance of complex international transactions by FAS Russia.</p> <p>The transaction was successfully completed on March 31st, 2020.</p> <p>To learn more about projects of our Antitrust Practice, please, click <a href="https://www.alrud.com/services/CompetitionAntitrust/" title="here">here</a>.</p>
